DK2193795T3 - Latanoprostholdig vandig farmaceutisk sammensætning - Google Patents
Latanoprostholdig vandig farmaceutisk sammensætningInfo
- Publication number
- DK2193795T3 DK2193795T3 DK08828329.6T DK08828329T DK2193795T3 DK 2193795 T3 DK2193795 T3 DK 2193795T3 DK 08828329 T DK08828329 T DK 08828329T DK 2193795 T3 DK2193795 T3 DK 2193795T3
- Authority
- DK
- Denmark
- Prior art keywords
- latanous
- sustainable
- pharmaceutical composition
- aqueous pharmaceutical
- aqueous
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007222316 | 2007-08-29 | ||
| JP2008002673 | 2008-01-10 | ||
| PCT/JP2008/065564 WO2009028674A1 (ja) | 2007-08-29 | 2008-08-29 | ラタノプロスト含有水性医薬組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2193795T3 true DK2193795T3 (da) | 2014-11-03 |
Family
ID=40387384
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK08828329.6T DK2193795T3 (da) | 2007-08-29 | 2008-08-29 | Latanoprostholdig vandig farmaceutisk sammensætning |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US9456980B2 (da) |
| EP (1) | EP2193795B1 (da) |
| JP (1) | JP5327809B2 (da) |
| KR (1) | KR101529093B1 (da) |
| DK (1) | DK2193795T3 (da) |
| ES (1) | ES2511840T3 (da) |
| PT (1) | PT2193795E (da) |
| WO (1) | WO2009028674A1 (da) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010119305A1 (en) * | 2009-04-14 | 2010-10-21 | Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi | Using of quaternary ammonium compounds in dissolving of latanoprost |
| EP2452669A1 (en) | 2010-10-29 | 2012-05-16 | Omnivision GmbH | Ophthalmic composition |
| CN103596572A (zh) * | 2011-04-12 | 2014-02-19 | 株式会社·R-技术上野 | 水性眼用组合物 |
| TW201340960A (zh) * | 2012-02-27 | 2013-10-16 | Rohto Pharma | 眼科用組成物套組 |
| PL2887923T3 (pl) | 2012-08-24 | 2023-08-14 | Sun Pharmaceutical Industries Limited | Preparat okulistyczny polioksylipidu lub polioksylowego kwasu tłuszczowego i leczenie chorób oczu |
| WO2015179527A1 (en) * | 2014-05-23 | 2015-11-26 | Ocular Technologies Sarl | Topical formulations and uses thereof |
| DK3373976T3 (da) | 2015-11-10 | 2024-04-02 | Sun Pharmaceutical Ind Ltd | Topiske formuleringer og anvendelser deraf |
| NZ785158A (en) | 2016-02-29 | 2025-03-28 | Sun Pharmaceutical Ind Ltd | Topical cyclosporine-containing formulations and uses thereof |
| KR101770324B1 (ko) * | 2016-11-09 | 2017-08-22 | 주식회사태준제약 | 안압 강하용 점안 조성물 |
| US12263119B2 (en) | 2018-07-09 | 2025-04-01 | Zaklady Farmaceutyczne Polpharma S.A. | Opthalmic dispensing device |
| EP4066817A1 (en) * | 2021-03-31 | 2022-10-05 | actrevo GmbH | Stable ophthalmic composition comprising latanoprost |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2729859B2 (ja) | 1993-04-16 | 1998-03-18 | わかもと製薬株式会社 | 可逆性熱ゲル化水性医薬組成物 |
| US5624962A (en) * | 1993-04-16 | 1997-04-29 | Wakamoto Pharmaceutical Co., Ltd. | Aqueous drug composition having property of reversible thermosetting gelation |
| US6235781B1 (en) * | 1998-07-14 | 2001-05-22 | Alcon Laboratories, Inc. | Prostaglandin product |
| CA2295512C (en) * | 1998-07-14 | 2009-05-26 | Alcon Laboratories, Inc. | Prostaglandin product |
| JP3876355B2 (ja) | 2000-09-13 | 2007-01-31 | 参天製薬株式会社 | 点眼液 |
| JP2003095924A (ja) | 2001-07-16 | 2003-04-03 | Wakamoto Pharmaceut Co Ltd | 熱ゲル化人工涙液 |
| ES2400177T3 (es) * | 2002-04-04 | 2013-04-08 | Nipro Corporation | Contenedor para medicamentos líquidos |
| JP4357159B2 (ja) | 2002-07-22 | 2009-11-04 | ニプロ株式会社 | 薬液容器 |
| JP4744775B2 (ja) | 2002-11-20 | 2011-08-10 | ニプロ株式会社 | 薬液容器 |
| JP2004123729A (ja) * | 2002-09-09 | 2004-04-22 | Santen Pharmaceut Co Ltd | ラタノプロストを有効成分とする澄明な点眼液 |
| CA2498233C (en) * | 2002-09-09 | 2012-08-14 | Santen Pharmaceutical Co., Ltd. | Clear ophthalmic solution comprising latanoprost as active ingredient |
| US7074827B2 (en) * | 2002-10-24 | 2006-07-11 | Sucampo Ag (Usa) Inc. | Method for treating ocular hypertension and glaucoma |
| US7947295B2 (en) * | 2003-06-13 | 2011-05-24 | Alcon, Inc. | Ophthalmic compositions containing a synergistic combination of two polymers |
| CA2839849C (en) * | 2003-06-13 | 2017-03-07 | Alcon, Inc. | Ophthalmic compositions containing a synergistic combination of two polymers |
| AU2004270543A1 (en) * | 2003-09-02 | 2005-03-17 | Otsuka Pharmaceutical Co., Ltd. | Discharge member, discharge container having the discharge member, and instillation container |
| EP1681065A4 (en) | 2003-10-31 | 2011-12-28 | Wakamoto Pharma Co Ltd | WATER-BASED COMPOSITION SUBJECTED TO REVERSIBLE THERMOREGULATION |
| JP2005160972A (ja) | 2003-11-10 | 2005-06-23 | Rohto Pharmaceut Co Ltd | 眼科用液剤入り容器及び眼科用液剤 |
| EP1708780A4 (en) * | 2003-11-14 | 2010-10-13 | Medical Instill Tech Inc | DISTRIBUTION DEVICE AND DISTRIBUTION METHOD |
| US20050287325A1 (en) * | 2004-06-25 | 2005-12-29 | Pharmacia & Upjohn Company | Pharmaceutical containers with low adsorption/absorption of active ingredients, and a method of testing materials for adsorption/absorption of active ingredients |
-
2008
- 2008-08-29 JP JP2009530211A patent/JP5327809B2/ja active Active
- 2008-08-29 WO PCT/JP2008/065564 patent/WO2009028674A1/ja not_active Ceased
- 2008-08-29 EP EP08828329.6A patent/EP2193795B1/en not_active Not-in-force
- 2008-08-29 US US12/674,962 patent/US9456980B2/en not_active Expired - Fee Related
- 2008-08-29 PT PT88283296T patent/PT2193795E/pt unknown
- 2008-08-29 ES ES08828329.6T patent/ES2511840T3/es active Active
- 2008-08-29 KR KR1020107005330A patent/KR101529093B1/ko not_active Expired - Fee Related
- 2008-08-29 DK DK08828329.6T patent/DK2193795T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2193795B1 (en) | 2014-10-01 |
| JP5327809B2 (ja) | 2013-10-30 |
| ES2511840T3 (es) | 2014-10-23 |
| EP2193795A4 (en) | 2013-09-18 |
| KR101529093B1 (ko) | 2015-06-16 |
| PT2193795E (pt) | 2014-10-22 |
| JPWO2009028674A1 (ja) | 2010-12-02 |
| KR20100056499A (ko) | 2010-05-27 |
| US9456980B2 (en) | 2016-10-04 |
| EP2193795A1 (en) | 2010-06-09 |
| WO2009028674A1 (ja) | 2009-03-05 |
| US20110065790A1 (en) | 2011-03-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LTC2140867I2 (lt) | Farmacinė kompozicija | |
| CY2018030I1 (el) | Φαρμακοτεχνικη μορφη 514 | |
| BRPI0721651A2 (pt) | Composição farmacêutica | |
| DK3097925T3 (da) | Farmaceutisk sammensætning | |
| BRPI1004940A2 (pt) | composição farmacêutica | |
| BRPI0920521A2 (pt) | combinação farmacêutica | |
| RU2493831C3 (ru) | Фармацевтические композиции | |
| LT3061445T (lt) | Labai koncentruotos farmacinės kompozicijos | |
| SMT201700095B (is) | Composizioni farmaceutiche per inalazione | |
| BRPI0715712A2 (pt) | Composição farmacêutica | |
| EP2419097A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
| EP2451274A4 (en) | Pharmaceutical compositions | |
| BRPI0719393A2 (pt) | Composição farmacêutica | |
| DK2120884T3 (da) | Farmaceutisk sammensætning | |
| DK2391349T3 (da) | Farmaceutisk sammensætning omfattende 2-oco-1-pyrrolidin-derivater | |
| BRPI1015939A2 (pt) | composição farmacêutica | |
| BRPI0720234A2 (pt) | Composição farmacêutica | |
| DK2285413T3 (da) | Farmaceutisk sammensætning | |
| EP2092892A4 (en) | ULTRASOUND DEVICE | |
| BRPI0716445A2 (pt) | composiÇço farmacÊutica | |
| BRPI0921654A2 (pt) | formulação farmacêutica | |
| EP2236149A4 (en) | MEDICAL COMPOSITION | |
| PT2209464E (pt) | Composição farmacêutica antimalárica | |
| BRPI0921313A2 (pt) | composição farmaucêutica | |
| EP2172224A4 (en) | AQUEOUS COMPOSITION |